revealed that COL5A1 positively correlated with latent transforming growth factor-beta binding protein 1 (LYBP1), and they might work together to promote tumor progression via regulation of extracellular matrix (ECM) in GBM (19). This evidence concerns the gene COL5A1 and glioblastoma.